Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Connect with this vendor - Learn about this product

Illumina - Next Generation Sequencing Platforms

Illumina sequencing platforms

Illumina's innovative next-generation sequencing (NGS) platforms deliver exceptional data quality and accuracy, at a massive scale. From benchtop to production-scale sequencing systems, you’ll find the right platform to advance your research. Illumina has pioneered major advances for sequencing platform simplicity, flexibility, and performance. Sequencing output has grown over a thousand-fold, from less than 1 gigabase to 6 terabases per run, while the number of reads has increased from millions to billions. Experiments that once required complex workflows now use simple push-button sequencing.

NGS Platforms with Proven Performance

Illumina NGS instruments have been adopted by leading institutions around the globe, both big and small, and are the production platform for all major genome centers. More than 90% of the world’s sequencing data is generated using Illumina instruments.*

Each sequencing platform delivers exceptional data quality and performance, with flexible throughput and simple, streamlined workflows—for every kind of researcher, for every scale of study.

*Data calculations on file, Illumina, Inc. 2015.